Harmony Biosciences Holdings, Inc. (HRMY)
38.51
+0.36
(+0.94%)
USD |
NASDAQ |
Aug 24, 16:00
38.51
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Shareholders Equity (Quarterly) : 999.24M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 999.24M |
| March 31, 2026 | 910.35M |
| December 31, 2025 | 870.22M |
| September 30, 2025 | 835.12M |
| June 30, 2025 | 773.08M |
| March 31, 2025 | 720.52M |
| December 31, 2024 | 659.16M |
| September 30, 2024 | 596.80M |
| June 30, 2024 | 538.58M |
| March 31, 2024 | 515.39M |
| December 31, 2023 | 466.99M |
| September 30, 2023 | 481.33M |
| June 30, 2023 | 485.17M |
| March 31, 2023 | 443.04M |
| Date | Value |
|---|---|
| December 31, 2022 | 402.84M |
| September 30, 2022 | 343.88M |
| June 30, 2022 | 246.53M |
| March 31, 2022 | 214.50M |
| December 31, 2021 | 186.51M |
| September 30, 2021 | 152.02M |
| June 30, 2021 | 126.55M |
| March 31, 2021 | 107.88M |
| December 31, 2020 | 97.18M |
| September 30, 2020 | 94.55M |
| June 30, 2020 | -483.36M |
| March 31, 2020 | -472.33M |
| December 31, 2019 | -422.86M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Liquidia Corp. | 195.11M |
| Repligen Corp. | 2.112B |
| Johnson & Johnson | 84.97B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| ANI Pharmaceuticals, Inc. | 597.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.373B |
| Total Liabilities (Quarterly) | 373.84M |
| Debt to Equity Ratio | 0.2211 |
| Current Ratio | 3.479 |
| Net Debt Paydown Yield | -0.13% |